fda semaglutide compounding warning november 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our What is a 503B outsourcing

While the FDA does not explicitly approve these medications for weight loss, semaglutide has received approval for weight management under the brand name Wegovy

Oncotarget 5 , 1266512674 (2014)

"Despite statements on your product labeling marketing your products for laboratory research purposes only and not for human consumption, medical use or veterinary use, evidence obtained from your website establishes that your products are intended to be drugs for human use," the agency wrote

To address this specific concern, Star Multispeciality Hospital introduces a comprehensive, multi-specialty reconstruction process: the GLP-1 makeover body contouring program

That's the kind of medicine we practice at Magnolia Functional Wellness in Southlake, and it's the only kind worth your time